TRCT
CNMD icon

Tower Research Capital (TRC)’s CONMED CNMD Stock Holding History

Tower Research Capital (TRC)’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$117K Buy
3,299
+1,425
+76% +$58K ﹤0.01% 2060
2025
Q4 		$76.1K Sell
1,874
-1,739
-48% -$75.6K ﹤0.01% 2137
2025
Q3 		$170K Sell
3,613
-635
-15% -$32.9K ﹤0.01% 1596
2025
Q2 		$221K Buy
4,248
+2,205
+108% +$121K 0.01% 1680
2025
Q1 		$123K Sell
2,043
-4,230
-67% -$273K ﹤0.01% 1655
2024
Q4 		$429K Buy
6,273
+2,532
+68% +$176K 0.01% 1169
2024
Q3 		$269K Sell
3,741
-898
-19% -$63.4K 0.01% 1348
2024
Q2 		$322K Buy
4,639
+3,059
+194% +$223K 0.01% 1708
2024
Q1 		$127K Sell
1,580
-6,256
-80% -$558K ﹤0.01% 1707
2023
Q4 		$858K Buy
7,836
+5,213
+199% +$539K 0.01% 960
2023
Q3 		$265K Sell
2,623
-1,518
-37% -$174K 0.01% 1255
2023
Q2 		$563K Buy
4,141
+3,377
+442% +$412K 0.02% 897
2023
Q1 		$79K Buy
764
+670
+713% +$64.8K ﹤0.01% 2073
2022
Q4 		$9K Sell
94
-7,100
-99% -$589K ﹤0.01% 4176
2022
Q3 		$576K Buy
7,194
+2,587
+56% +$244K 0.01% 1031
2022
Q2 		$441K Buy
4,607
+4,416
+2,312% +$530K 0.01% 1219
2022
Q1 		$28K Sell
191
-727
-79% -$102K ﹤0.01% 3216
2021
Q4 		$131K Sell
918
-598
-39% -$84.7K ﹤0.01% 2055
2021
Q3 		$198K Sell
1,516
-3,054
-67% -$400K 0.01% 1831
2021
Q2 		$628K Buy
4,570
+2,709
+146% +$371K 0.02% 990
2021
Q1 		$243K Buy
1,861
+860
+86% +$104K ﹤0.01% 1848
2020
Q4 		$112K Sell
1,001
-21,734
-96% -$2.06M ﹤0.01% 2229
2020
Q3 		$1.79M Buy
22,735
+19,712
+652% +$1.61M 0.02% 471
2020
Q2 		$218K Buy
3,023
+1,981
+190% +$138K 0.01% 1715
2020
Q1 		$60K Buy
+1,042
New +$96.1K ﹤0.01% 1204
2019
Q4 		– Sell
-873
Closed -$84K – 3639
2019
Q3 		$84K Sell
873
-215
-20% -$20.2K 0.01% 1458
2019
Q2 		$93K Buy
1,088
+796
+273% +$65.4K 0.01% 1209
2019
Q1 		$24K Buy
292
+112
+62% +$8.14K ﹤0.01% 2160
2018
Q4 		$12K Buy
+180
New +$12.3K ﹤0.01% 2309
2018
Q3 		– Sell
-232
Closed -$17K – 3814
2018
Q2 		$17K Buy
+232
New +$15.8K ﹤0.01% 2517
2017
Q4 		– Sell
-2,810
Closed -$147K – 3569
2017
Q3 		$147K Buy
+2,810
New +$141K 0.01% 1006
2017
Q1 		– Sell
-233
Closed -$10K – 3150
2016
Q4 		$10K Buy
+233
New +$9.9K ﹤0.01% 2632
2016
Q3 		– Sell
-663
Closed -$31K – 3724
2016
Q2 		$31K Buy
663
+459
+225% +$19.4K ﹤0.01% 1903
2016
Q1 		$9K Sell
204
-162
-44% -$6.36K ﹤0.01% 2035
2015
Q4 		$16K Sell
366
-1,405
-79% -$61K ﹤0.01% 1527
2015
Q3 		$85K Buy
1,771
+200
+13% +$11K 0.01% 654
2015
Q2 		$92K Buy
1,571
+626
+66% +$33.8K 0.01% 904
2015
Q1 		$48K Buy
945
+84
+10% +$4.12K 0.01% 1495
2014
Q4 		$39K Buy
861
+299
+53% +$12.5K ﹤0.01% 1176
2014
Q3 		$20K Buy
+562
New +$22.3K ﹤0.01% 2288
2014
Q2 		– Sell
-256
Closed -$11K – 4081
2014
Q1 		$11K Buy
256
+68
+36% +$3.03K ﹤0.01% 2492
2013
Q4 		$8K Buy
188
+147
+359% +$5.59K ﹤0.01% 3179
2013
Q3 		$1K Buy
+41
New +$1.34K ﹤0.01% 4280

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Tower Research Capital (TRC)'s CNMD Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its CONMED (CNMD) stake by 76% in Q1 2026, buying an estimated $58K and bringing the position to 3,299 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #2060.

Tower Research Capital (TRC) first reported a position in CNMD in Q3 2013 and has held it in 43 quarters since. The position peaked at $1.79M in Q3 2020. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Tower Research Capital (TRC) held 3,299 shares of CONMED worth $117K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,425 CONMED shares in Q1 2026, an estimated $58K.
  • CONMED made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2060 holding.
  • Tower Research Capital (TRC) first reported a position in CONMED in Q3 2013 and has held it in 43 quarters since.
  • Tower Research Capital (TRC)'s CONMED position peaked at $1.79M in Q3 2020.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.